$SRDX

Surmodics, Inc.

  • NASDAQ
  • Health Technology
  • Medical Specialties
  • Manufacturing
  • Surgical and Medical Instrument Manufacturing

PRICE

$37.28 ▲0.893%

Delayed Price

VOLUME

4,154

DAY RANGE

- 37.55

52 WEEK

32.43 - 62.27

Key Metrics

Market Cap

516.93 M

Beta

1.25

Avg. Volume

45.06 K

Shares Outstanding

13.99 M

Yield

0%

Public Float

0

Next Earnings Date

2022-08-03

Next Dividend Date

Company Information

Surmodics is the global leader in surface modification technologies for intravascular medical devices and a leading provider of chemical components for in vitro diagnostic (IVD) immunoassay tests and microarrays. Surmodics is pursuing highly differentiated medical devices that are designed to address unmet clinical needs and engineered to the most demanding requirements. This key growth strategy leverages the combination of the Company's expertise in proprietary surface technologies, along with enhanced device design, development, and manufacturing capabilities. The Company mission remains to improve the detection and treatment of disease. Surmodics is headquartered in Eden Prairie, Minnesota. For more information, visit www.surmodics.com. The content of Surmodics' website is not part of this press release or part of any filings that the company makes with the SEC.

CEO: Gary Maharaj

Website:

HQ: 9924 W 74th St Eden Prairie, 55344-3523 Minnesota

Related News